Connect Biopharma Holdings Limited
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -61.2% | -61.2% | -48.8% |
| FY2024 | -17.0% | -17.0% | -15.4% |
| FY2025 | -132.2% | -132.2% | -98.9% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2023 | -61.2% | -61.2% | -48.8% |
| FY2024 | -17.0% | -17.0% | -15.4% |
| FY2025 | -132.2% | -132.2% | -98.9% |